Haohua Zhu
Beijing Key Laboratory Of Key Technologies For Early Clinical Trial Evaluation Of Innovative Drugs For Major Diseases, Chinese Academy Of Medical Sciences & Peking Union Medical College
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Anlotinib Plus Sintilimab for BRAFV600E Negative Unresectable or Metastatic Anaplastic Thyroid Carcinoma: A Single-Center, Single-Arm, Phase 2 Trial.
Journal: Thyroid : official journal of the American Thyroid Association
Published: January 24, 2026
Digital spatial profiling uncovers transcriptomic features of distinct plasma cell-like phenotypes in diffuse large B-cell lymphoma.
Journal: Blood advances
Published: August 18, 2025
Efficacy and Safety of Firmonertinib Plus Anlotinib as First-Line Treatment for Advanced NSCLC With EGFR Mutations: A Single-Arm, Phase I/II Trial.
Journal: Clinical lung cancer
Published: August 15, 2025
Prevalence and risk factors of lung nodules in a non-smoking Chinese population: a prospective study of low-dose computed tomography screening.
Journal: BMC pulmonary medicine
Published: August 03, 2025
Efficacy and Safety of Afatinib Plus Bevacizumab as First-Line Treatment for Advanced NSCLC Patients With Epidermal Growth Factor Receptor (EGFR) Mutations: A Multicenter, Phase II Trial.
Journal: Thoracic cancer
Published: June 09, 2025
Immune checkpoint inhibitors for the treatment of solid tumors and lymphoma in the past 26 years (2000-2025).
Journal: Journal of hematology & oncology
Published: May 24, 2025
Clinical, immune cell, and genetic features predicting survival and long-term response to first-line chemo-immunotherapy treatment for non-small cell lung cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: December 27, 2024
Neurokinin-1 receptor antagonists in the current management of chemotherapy-induced nausea and vomiting.
Journal: Frontiers of medicine
Published: October 21, 2024
Proteomic profiling reveals the significance of lipid metabolism in small cell lung cancer recurrence and metastasis.
Journal: Journal of translational medicine
Published: September 05, 2024
Efficacy, safety, and multi-omics analysis of pembrolizumab combined with nab-paclitaxel and platinum as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: A single-arm phase 2 study.
Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
Published: August 27, 2024
Multi-omics analysis and response prediction of PD-1 monoclonal antibody containing regimens in patients with relapsed/refractory diffuse large B-cell lymphoma.
Journal: Cancer immunology, immunotherapy : CII
Published: August 07, 2024
A 16-year evaluation of opportunistic lung cancer screening with low-dose CT in China: comparative findings between non-smokers and smokers.
Journal: BMC cancer
Published: July 19, 2024
Last Updated: 09/26/2026